News
Twitter
Videos
Images
Events
News For Mylan
This RSS feed URL is deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Google
11/21/2018 5:01:41 PM
Mylan taken to task for manufacturing failings at key plant - BioPharma Dive
STAT
Mylan
taken to task for manufacturing failings at key plant
BioPharma Dive
The Food and Drug Administration has made official its concerns with
Mylan's
handling of operations at its largest manufacturing plant, issuing a sharply critical warning letter earlier this month that lays out a series of missteps and oversights at
...
Mylan
is scolded by the FDA for manufacturing gaffes at a key plant
STAT
Mylan
Recalls Valsartan Lots, Gets FDA Warning for Facility
Zacks.com
FDA warns
Mylan
over Morgantown plant
Pittsburgh Business Times
In-PharmaTechnologist.com
all 7 news articles »
Google
11/21/2018 4:34:00 PM
Mylan Stock Under Pressure After FDA Letter - Schaeffers Research (blog)
Schaeffers Research (blog)
Mylan
Stock Under Pressure After FDA Letter
Schaeffers Research (blog)
The shares of
Mylan
N.V. (NASDAQ:MYL) are down 0.6% to trade at $33.70 this morning, after the drugmaker disclosed a warning letter from the Food and Drug Administration (FDA) dated Nov. 9, detailing concerns about conditions at a facility in West ...
MYL Stock:
Mylan
NV (MYL) Is Still Worth a Bite
Financial Mercury
Cantor Fitzgerald Reaffirms Hold Rating for
Mylan
(MYL)
Fairfield Current
Stock alteration::
Mylan
NV, (NASDAQ: MYL)
StocksNewsPro (press release)
The RNS Daily
-
Wall Street Morning
-
Post Analyst
-
Zacks
all 89 news articles »
Google
11/21/2018 3:15:00 PM
The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO - Benzinga
Benzinga
The Daily Biotech Pulse:
Mylan
Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO
Benzinga
Mylan
NV (NASDAQ: MYL) announced a nationwide recall of select lots of Valsartan containing products, citing the presence of trace amounts of N-nitrosodiethylamine, an impurity. The recalled products were manufactured by
Mylan
Pharma and
Mylan
Labs, ...
Google
11/21/2018 1:04:45 PM
Dr. Reddy's, Mylan Win Challenge To Arthritis Drug Patents - Law360
Dr. Reddy's,
Mylan
Win Challenge To Arthritis Drug Patents
Law360
Law360 (November 20, 2018, 9:04 PM EST) -- A New Jersey federal judge on Monday invalidated patents covering Horizon Pharma Inc.'s arthritis drug Vimovo in its suit against Dr. Reddy's Laboratories Inc. and
Mylan
Pharmaceuticals Inc. over their plans
...
Google
11/21/2018 2:04:00 AM
Mylan gets FDA warning letter over infractions at West Virginia plant - Reuters
FiercePharma
Mylan
gets FDA warning letter over infractions at West Virginia plant
Reuters
(Reuters) -
Mylan
NV said on Tuesday it is addressing issues raised in a warning letter it received earlier this month from the U.S. Food and Drug Administration, which flagged concerns regarding the drugmaker's manufacturing plant in West Virginia.
Mylan
lower after FDA warning
Seeking Alpha
Mylan
West Virginia plant tagged with warning letter by FDA
FiercePharma
Mylan
Statement in Response to FDA Warning Letter Relating to Morgantown Plant
PRNewswire (press release)
FDA
all 56 news articles »
Google
11/20/2018 11:29:00 PM
Europe suspends use of Mylan's Hyderabad-made valsartan - In-PharmaTechnologist.com
In-PharmaTechnologist.com
Europe suspends use of
Mylan's
Hyderabad-made valsartan
In-PharmaTechnologist.com
The detection of N-nitrosodiethylamine (NDEA) in some of
Mylan's
valsartan batches prompted the decision. NDEA and the related compound N-nitrosodimethylamine (NDMA) are classified by the International Agency for Research on Cancer as probable ...
European authorities suspend
Mylan's
manufacturing license for hypertension drug
Pittsburgh Business Times
all 4 news articles »
Google
11/20/2018 2:37:35 PM
EU cracks down on blood pressure medicine made by Mylan - Reuters
Reuters
EU cracks down on blood pressure medicine made by
Mylan
Reuters
(Reuters) - European Union authorities on Monday stepped in to effectively ban sales of blood pressure medicine valsartan made by an India-based unit of
Mylan
NV after some batches were found to contain a probable cancer-causing impurity, the latest in
...
EMA Warns of Impurity in Valsartan From
Mylan
Regulatory Focus
European regulators pull
Mylan's
manufacturing license for valsartan after impurities found
Seeking Alpha
European authorities crack down on blood pressure medicine made by
Mylan
Nasdaq
European Medicines Agency - Europa EU
all 27 news articles »
Google
11/19/2018 8:29:20 PM
1
2